Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
A129816-250mg
|
250mg |
4
|
$44.90
|
|
|
A129816-1g
|
1g |
5
|
$89.90
|
|
|
A129816-5g
|
5g |
2
|
$269.90
|
|
|
A129816-10g
|
10g |
1
|
$431.90
|
|
|
A129816-25g
|
25g |
1
|
$863.90
|
|
Potent α-glucosidase inhibitor
| Synonyms | Bay-g 5421 | BAY g 5421 | Bay g 5421 | BRD-A16444946-001-07-1 | MLS001424056 | AB00639959-06 | HMS2093I22 | MFCD00869592 | Prandase; | SR-01000759407 | SBI-0206777.P001 | acarbose | MD-0230 | SR-01000759407-4 | Acarbose; O-4,6-Dideoxy-4-[[(1S,4R,5S,6S)-4, |
|---|---|
| Specifications & Purity | Moligand™, ≥98% |
| Biochemical and Physiological Mechanisms | Potent α-glucosidase inhibitor (IC 50 = 11 nM). Orally active. Antidiabetic. |
| Storage Temp | Store at -20°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Grade | Moligand™ |
| Action Type | INHIBITOR |
| Mechanism of action | Inhibitor of amylase alpha 2A;Inhibitor of maltase-glucoamylase |
| Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
| Product Description |
Acarbose, also known as BAY g 5421, is an α-glucosidase inhibitor that prevents absorption of sucrose and maltose. This compound has been found to delay digestion of complex disaccharides and carbohydrates. Further studies suggest that this compound can stimulate phosphorylase kinase (PhK) by binding to the glucoamylase-like domain new the amino termini and causing an alteration in the structure. Application: Acarbose, a derivitized maltotriose antidiabetic drug, is a reversible α-glucosidase inhibitor used in medical studies to control the effects of Type II diabetes. Acarbose is often used as a reference to which other α-glucosidase inhibitors are compared. |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic oxygen compounds |
| Class | Organooxygen compounds |
| Subclass | Carbohydrates and carbohydrate conjugates |
| Intermediate Tree Nodes | Aminosaccharides - Aminoglycosides |
| Direct Parent | Aminocyclitol glycosides |
| Alternative Parents | Oligosaccharides O-glycosyl compounds Oxanes Cyclitols and derivatives Secondary alcohols Hemiacetals 1,2-aminoalcohols Polyols Oxacyclic compounds Dialkylamines Acetals Primary alcohols Organopnictogen compounds Hydrocarbon derivatives |
| Molecular Framework | Aliphatic heteromonocyclic compounds |
| Substituents | Oligosaccharide - Amino cyclitol glycoside - Glycosyl compound - O-glycosyl compound - Cyclitol or derivatives - Oxane - 1,2-aminoalcohol - Hemiacetal - Secondary alcohol - Secondary amine - Organoheterocyclic compound - Acetal - Oxacycle - Secondary aliphatic amine - Polyol - Organonitrogen compound - Organic nitrogen compound - Hydrocarbon derivative - Organopnictogen compound - Amine - Primary alcohol - Alcohol - Aliphatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as aminocyclitol glycosides. These are organic compounds containing an amicocyclitol moiety glycosidically linked to a carbohydrate moiety. There are two major classes of aminoglycosides containing a 2-streptamine core. They are called 4,5- and 4,6-disubstituted 2-deoxystreptamines. |
| External Descriptors | tetrasaccharide derivative |
|
|
|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Pubchem Sid | 488183332 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488183332 |
| IUPAC Name | (3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol |
| INCHI | InChI=1S/C25H43NO18/c1-6-11(26-8-2-7(3-27)12(30)15(33)13(8)31)14(32)19(37)24(40-6)43-22-10(5-29)42-25(20(38)17(22)35)44-21-9(4-28)41-23(39)18(36)16(21)34/h2,6,8-39H,3-5H2,1H3/t6-,8+,9-,10-,11-,12-,13+,14+,15+,16-,17-,18-,19-,20-,21-,22-,23?,24-,25-/m1/s1 |
| InChIKey | XUFXOAAUWZOOIT-UGEKTDRHSA-N |
| Smiles | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO |
| Isomeric SMILES | C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](OC([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO |
| RTECS | LZ7153000 |
| Molecular Weight | 645.61(as Anhydrous) |
| Reaxy-Rn | 24713589 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=24713589&ln= |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jun 09, 2025 | A129816 | |
| Certificate of Analysis | Apr 18, 2025 | A129816 | |
| Certificate of Analysis | Apr 18, 2025 | A129816 | |
| Certificate of Analysis | Apr 18, 2025 | A129816 | |
| Certificate of Analysis | Apr 18, 2025 | A129816 | |
| Certificate of Analysis | Apr 18, 2025 | A129816 | |
| Certificate of Analysis | Dec 06, 2024 | A129816 | |
| Certificate of Analysis | Dec 06, 2024 | A129816 | |
| Certificate of Analysis | Nov 09, 2024 | A129816 | |
| Certificate of Analysis | Nov 09, 2024 | A129816 | |
| Certificate of Analysis | Nov 09, 2024 | A129816 | |
| Certificate of Analysis | Sep 05, 2024 | A129816 | |
| Certificate of Analysis | Sep 05, 2024 | A129816 | |
| Certificate of Analysis | Sep 05, 2024 | A129816 | |
| Certificate of Analysis | Sep 05, 2024 | A129816 | |
| Certificate of Analysis | Jun 14, 2024 | A129816 | |
| Certificate of Analysis | Jun 14, 2024 | A129816 | |
| Certificate of Analysis | Jun 14, 2024 | A129816 | |
| Certificate of Analysis | Jun 14, 2024 | A129816 | |
| Certificate of Analysis | Jun 14, 2024 | A129816 | |
| Certificate of Analysis | Jun 14, 2024 | A129816 | |
| Certificate of Analysis | Jan 05, 2024 | A129816 | |
| Certificate of Analysis | Feb 13, 2023 | A129816 | |
| Certificate of Analysis | Feb 13, 2023 | A129816 | |
| Certificate of Analysis | Feb 13, 2023 | A129816 | |
| Certificate of Analysis | Feb 18, 2022 | A129816 | |
| Certificate of Analysis | Feb 18, 2022 | A129816 | |
| Certificate of Analysis | Feb 18, 2022 | A129816 | |
| Certificate of Analysis | Feb 18, 2022 | A129816 | |
| Certificate of Analysis | Feb 18, 2022 | A129816 | |
| Certificate of Analysis | Feb 18, 2022 | A129816 | |
| Certificate of Analysis | Feb 18, 2022 | A129816 | |
| Certificate of Analysis | Feb 18, 2022 | A129816 | |
| Certificate of Analysis | Feb 18, 2022 | A129816 |
| Solubility | Soluble in water (100 mM), DMSO (100 mM), and methanol. |
|---|---|
| Specific Rotation[α] | 176° (C=1,H2O) |
| Molecular Weight | 645.600 g/mol |
| XLogP3 | -8.500 |
| Hydrogen Bond Donor Count | 14 |
| Hydrogen Bond Acceptor Count | 19 |
| Rotatable Bond Count | 9 |
| Exact Mass | 645.248 Da |
| Monoisotopic Mass | 645.248 Da |
| Topological Polar Surface Area | 321.000 Ų |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 962.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 18 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
Starting at $166.90